Company / Income Tax
Jade Biosciences, Inc. Income Tax History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$55.0K
FY2024
5-year range
$3.0K / $56.0K
FY2021-FY2024
Trend
-1.8%
vs FY2023
Sector context
#110 of 200
Health Care
What the data says
At $55,000, Jade Biosciences, Inc.'s income tax ranks #91 of 200 in the Health Care sector. Increased from $25,000 to $55,000 over the past 2 years.
Based on SEC 10-K filings.
$55,000 in FY2024 with a 3-year CAGR of +163.7%.
Increased from $25,000 to $55,000 over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- +163.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#91 of 200 in Health CareTop 45% of 200This company $55.0K Sector average $126.4M
▼
-100.0% below sector average
Key checks
Key Insights
- 3-year CAGR of +163.7%, indicating consistent growth.
- In FY2024, income tax decreased 1.8% year-over-year.
- Ranks #110 out of 200 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 6.03 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $55.0K | -1.8% |
| FY2023 | $56.0K | +124.0% |
| FY2022 | $25.0K | +733.3% |
| FY2021 | $3.0K | - |
| FY2020 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026